Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 33,333 | 0 | 0 | 0 | 0 |
| Gross Profit | 33,333 | N/A | N/A | N/A | N/A |
| Operating Expenses | 67,014 | 64,143 | 78,069 | 67,406 | 65,269 |
| Operating Income | -33,681 | -64,143 | -78,069 | -67,406 | -65,269 |
| Interest Expense | 2,184 | 1,425 | 3,657 | 3,788 | 3,793 |
| Other Income | 3,677 | 717 | -3,687 | 821 | 1,471 |
| Pre-tax Income | -32,188 | -64,851 | -85,413 | -70,373 | -67,591 |
| Income Tax | 672 | 62 | 191 | 195 | 313 |
| Net Income Continuous | -32,860 | -64,913 | -85,604 | -70,568 | -67,904 |
| Net Income | $-32,860 | $-64,913 | $-85,604 | $-70,568 | $-67,904 |
| EPS Basic Total Ops | -0.37 | -0.73 | -0.96 | -0.79 | -0.89 |
| EPS Basic Continuous Ops | -0.37 | -0.72 | -0.96 | -0.79 | -0.89 |
| EPS Diluted Total Ops | -0.37 | -0.73 | -0.96 | -0.79 | -0.89 |
| EPS Diluted Continuous Ops | -0.37 | -0.72 | -0.96 | -0.79 | -0.89 |
| EBITDA(a) | $-33,130 | $-63,614 | $-77,168 | $-66,496 | $-64,358 |